Free tool
FAERS Monitor: Calcium Chloride 10% In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021117 or its brand name (Calcium Chloride 10% In Plastic Container, Calcium Chloride). Reports on generic versions are filed under their own applications.
Reports
3,113
Serious
2,812
90% of reports
Hospitalization
1,413
Death reported
734
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- pain434
- drug ineffective425
- injury414
- nausea358
- off label use336
- anxiety295
- renal failure276
- pyrexia274
- dyspnoea254
- hypotension251
- condition aggravated242
- pemphigus230
- oedema226
- vomiting224
- pneumonia223
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 14 |
| 2005 | 11 |
| 2006 | 31 |
| 2007 | 584 |
| 2008 | 30 |
| 2009 | 21 |
| 2010 | 46 |
| 2011 | 240 |
| 2012 | 84 |
| 2013 | 32 |
| 2014 | 68 |
| 2015 | 41 |
| 2016 | 53 |
| 2017 | 86 |
| 2018 | 137 |
| 2019 | 135 |
| 2020 | 162 |
| 2021 | 159 |
| 2022 | 190 |
| 2023 | 246 |
| 2024 | 315 |
| 2025 | 249 |
| 2026 | 179 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,046 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| pemphigusSignal | 230 | 126.6 | 111.7 | 28,030 |
| injurySignal | 414 | 40.0 | 36.6 | 15,670 |
| oedemaSignal | 226 | 28.3 | 24.9 | 5,908 |
| renal failureSignal | 276 | 14.1 | 12.6 | 3,352 |
| hypotensionSignal | 251 | 8.5 | 7.5 | 1,658 |
| anxietySignal | 295 | 7.0 | 6.3 | 1,533 |
| condition aggravatedSignal | 242 | 5.4 | 4.8 | 871 |
| pyrexiaSignal | 274 | 5.4 | 4.8 | 981 |
| painSignal | 434 | 4.8 | 4.4 | 1,330 |
| pneumoniaSignal | 223 | 4.7 | 4.1 | 646 |
| vomitingSignal | 224 | 3.2 | 2.8 | 348 |
| nauseaSignal | 358 | 3.1 | 2.8 | 513 |
| dyspnoeaSignal | 254 | 3.0 | 2.7 | 353 |
| off label useSignal | 336 | 2.6 | 2.3 | 341 |
| drug ineffectiveSignal | 425 | 2.2 | 2.0 | 288 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.